Kitzes R, Ackerman Z, Levy M, Frumerman I, Shved A, Garty M
Isr J Med Sci. 1985 Apr;21(4):323-6.
Crossover studies, following single oral doses given to 19 healthy volunteers were conducted to compare the bioavailability of three phenytoin preparations: DANTOIN and IDANTOIN (Teva, Israel) and EPANUTIN (Parke-Davis, USA). The first has recently replaced the second as the only preparation available in Israel for alleged better bioavailability. The area under the serum concentration time curve (AUCo----48), however, did not significantly differ between preparations, indicating equivalent absorption of the three preparations. These results suggest that no overall adjustments are required when switching from one preparation to another.
对19名健康志愿者单次口服给药后进行了交叉研究,以比较三种苯妥英制剂的生物利用度:DANTOIN和IDANTOIN(以色列梯瓦制药公司)以及EPANUTIN(美国辉瑞制药公司)。第一种制剂最近已取代第二种制剂,成为以色列唯一可用的制剂,据称其生物利用度更高。然而,血清浓度-时间曲线下面积(AUCo----48)在各制剂之间并无显著差异,表明这三种制剂的吸收相当。这些结果表明,从一种制剂转换为另一种制剂时无需进行全面调整。